Epica International, Inc.

Epica International has been developing the world’s most innovative mobile and multimodality (HDVI-CT, Fluoroscopy and DR), “point of care anywhere”, ultra-high-resolution, diagnostic, and interoperative imaging platform solutions available supporting animal health and pre-clinical research. Epica’s Animal Health Imaging Platforms are capable of identifying sub 0.2mm lesions and anatomies as small as the vasculature of a hummingbird with less radiation dose and cost. Epica’s Animal Health Division is the definitive market leader in this important imaging category with more than 300 Epica Vimago and Pegaso deployments in veterinary, academia, government life science, and pharma segments.